Close X
Thursday, November 14, 2024
ADVT 
National

Officials face battle of confidence in AstraZeneca

Darpan News Desk The Canadian Press, 16 Mar, 2021 05:53 PM
  • Officials face battle of confidence in AstraZeneca

Federal officials are mounting a renewed push to instill Canadian confidence in Oxford-AstraZeneca’s COVID-19 vaccine, but observers predict they're in for a tough battle.

Members of the federal body tasked with advising the country on vaccine use took the unusual step of addressing public fears in a televised press conference Tuesday that stressed the vaccine’s safety for those over the age of 65.

The assurances come as new information leads to an update on previous advice, which initially suggested that seniors avoid the AstraZeneca vaccine because of insufficient trial data. NACI chair Dr. Caroline Quach-Thanh says there is now enough "real-world evidence" to show it is both safe and effective for seniors.

Infectious disease doctor Zain Chagla says it's an important message, but confusing for Canadians as Germany and other European countries move to limit the vaccine's use while they investigate reports of blood clots emerging after some inoculations.

The European Medicines Agency says there is no evidence of a safety concern and is "firmly convinced" that the benefits of the AstraZeneca shot outweigh the risks.

But Chagla says unfounded doubts about efficacy and safety have been deeply sown and some people will have a hard time accepting updated advice.

Reached earlier this week as he anticipated NACI's revised guidelines, he noted the AstraZeneca product has been hit especially hard in recent weeks, on multiple fronts.

“Even if all of the dust settles on all of this stuff and it's (proven) effective in 65-year-olds and it's actually 80 per cent effective and there's no clot risk, you've already introduced three strikes that are hard to wash away from people who are already hesitant to take this vaccine over Moderna and Pfizer," Chagla, a specialist at St. Joseph's Healthcare Hamilton.

Chagla said it’s up to NACI, Health Canada, and the various provincial health ministries to be transparent and clear on the evidence.

"This needs to be aggressively put out and people need to be really, really, really transparent, open and honest about this."

MORE National ARTICLES

B.C. gets 1.7 million calls as vaccine lines open

B.C. gets 1.7 million calls as vaccine lines open
Dix says the "enormous" response today reflects the significant support for vaccination in the province.

B.C. gets 1.7 million calls as vaccine lines open

Committee expands probe into military misconduct

Committee expands probe into military misconduct
The committee members will also ask Defence Minister Harjit Sajjan back to clarify what opposition members say are contradictions between his testimony and that of former military ombudsman Gary Walbourne.

Committee expands probe into military misconduct

Canada set to receive 910K vaccine doses this week

Canada set to receive 910K vaccine doses this week
The remaining 465,000 shots are expected from Moderna, as the pharmaceutical firm steps up its delivery schedule from once every three weeks to once every two.

Canada set to receive 910K vaccine doses this week

Low-wage women hit hardest by COVID-19: report

Low-wage women hit hardest by COVID-19: report
Employment among women remains about 5.3 per cent below where it sat in February 2020 just before the first wave of COVID-19, compared to about 3.7 per cent for men.

Low-wage women hit hardest by COVID-19: report

Don't let COVID-19 undo progress for women: PM

Don't let COVID-19 undo progress for women: PM
The prime minister says politicians should listen to the voices of women, not only when it comes to economic recovery but also on fighting systemic racism, climate change and gender-based violence.

Don't let COVID-19 undo progress for women: PM

Pfizer first planned February rollout in Canada

Pfizer first planned February rollout in Canada
On Aug. 1, Canada signed an agreement with Pfizer to buy at least 20 million doses, with the option to buy 56 million more, and approval was not expected until early 2021.

Pfizer first planned February rollout in Canada